In summary, in cisplatin-resistant gastric cancer cells, JWA is involved in reversing the chemoresistance process by blocking the XRCC1-dependent DNA repair pathway and promoting the DR4 receptor-dependent apoptosis pathway (Figure 3D). The gene discussed is ARL6IP5; the disease is gastric cancer.